A new glance on R2MGe6 (R = rare earth metal, M = another metal) compounds. An experimental and theoretical study of R2PdGe6germanides

The R2PdGe6series (R = rare earth metal) was structurally characterized, and the results achieved were extended for a comprehensive study on R2MGe6(M = another metal) compounds, employing symmetry-based structural rationalization and energy calculations. Directly synthesized R2PdGe6exists for almost all R-components (R = Y, La-Nd, Sm and Gd-Lu) and even if with La is probably metastable. Several single crystal X-ray analyses (R = Y, Ce, Pr, Nd, Er and Lu) indicated oS72-Ce2(Ga0.1Ge0.9)7as the correct structure. The alternative In-flux method, once optimized, produced three good quality R2PdGe6single crystals: La2PdGe6and Pr2PdGe6turned out to be mS36-La2AlGe6-type non-merohedrally twinned crystals and Yb2PdGe6is of oS72-Ce2(Ga0.1Ge0.9)7-type. The vacancy ordering phenomenon was considered as a possible cause of the symmetry reduction relations connecting the most frequently reported 2:1:6 structural models (oS18, oS72 and mS36) with the oS20-SmNiGe3aristotype. The detected twin formation is consistent with the symmetry relations, which are discussed even considering the validity of the different structural models. DFT total energy calculations were performed for R2PdGe6(R = Y and La) in the three abovementioned structural models, and for La2MGe6(M = Pt, Cu, Ag and Au) in the oS18 and oS72 modifications. The results indicate that the oS18-Ce2CuGe6structure, prevalently proposed in the literature, is associated with the highest energy and thus it is not likely to be realized in these series. The oS72 and mS36 polytypes are energetically equivalent, and small changes in the synthetic conditions could easily stabilize any of them, in agreement with experimental results obtained by direct and flux syntheses

Lu5Pd4Ge8 and Lu3Pd4Ge4: Two more germanides among polar intermetallics

In this study, two novel Lu5Pd4Ge8and Lu3Pd4Ge4polar intermetallics were prepared by direct synthesis of pure constituents. Their crystal structures were determined by single crystal X-ray diffraction analysis: Lu5Pd4Ge8is monoclinic, P21/m, mP34, a = 5.7406(3), b = 13.7087(7), c = 8.3423(4) \uc5, \u3b2 = 107.8(1), Z = 2; Lu3Pd4Ge4is orthorhombic, Immm, oI22, a = 4.1368(3), b = 6.9192(5), c = 13.8229(9) \uc5, Z = 2. The Lu5Pd4Ge8analysed crystal is one more example of non-merohedral twinning among the rare earth containing germanides. Chemical bonding DFT studies were conducted for these polar intermetallics and showing a metallic-like behavior. Gathered results for Lu5Pd4Ge8and Lu3Pd4Ge4permit to described both of them as composed by [Pd\u2013Ge]\u3b4\u2013three dimensional networks bonded to positively charged lutetium species. From the structural chemical point of view, the studied compounds manifest some similarities to the Zintl phases, containing well-known covalent fragment i.e., Ge dumbbells as well as unique cis-Ge4units. A comparative analysis of molecular orbital diagrams for Ge26\u2013and cis-Ge10\u2013anions with COHP results supports the idea of the existence of complex Pd\u2013Ge polyanions hosting covalently bonded partially polarised Ge units. The palladium atoms have an anion like behaviour and being the most electronegative cause the noticeable variation of Ge species charges from site to site. Lutetium charges oscillate around +1.5 for all crystallographic positions. Obtained results explained why the classical Zintl-Klemm concept can\u2019t be applied for the studied polar intermetallics

Domestic wastewater treatment using Pt,Ni-RE (rare earth) electrodes

Electrochemical technologies can be used for the treatment of domestic wastewaters, by eliminating their organic pollutants. They have advantages over conventional methods, such as environmental compatibility, versatility, energy efficiency, safety and cost. The organic compounds degradation process is based on the production of OH radicals, formed during water electrolysis, which oxidize the organic molecules to CO2. At the same time, hydrogen (H-2) is produced through reduction of the water in the effluent, which can be later used in a fuel cell. Present study seeks to find effective electrocatalysts to produce H-2 by electrolysis, using domestic wastewaters as the hydrogen source, with or without the addition of supporting electrolyte. Herein KOH is used as the supporting electrolyte, as the extra hydroxide can be used to degrade the organic matter. Nine different electrode materials are evaluated as cathodes for the hydrogen evolution reaction (HER) in a domestic wastewater. The tested materials include platinum (Pt) and platinum-rare earth (Pt-RE) binary alloys, and nickel (Ni) and Ni-RE alloys, with the REs being cerium (Ce), samarium (Sm), dysprosium (Dy), and holmium (Ho). Linear scan voltammetry measurements are conducted at temperatures ranging from 25 to 85 degrees C. Several kinetic parameters are calculated, such as the Tafel slopes, charge transfer coefficients and exchange current densities. The data obtained at the different electrode materials is compared and it is clear that Pt-RE alloys show superior activity for the HER. It is also noticeable that the wastewater effluent containing the supporting electrolyte leads to significantly better HER performances

Учет расчетов с персоналом по оплате труда в бюджетных организациях (на примере МБОУ «Красноярская СОШ»)

Изучить теоретические аспекты бухгалтерского учета оплаты труда работников образовательного учреждения, нормативно-правовое регулирование оплаты труда работников бюджетной сферы. Рассмотреть практические аспекты ведения бухгалтерского учета оплаты труда в бюджетном учреждении. Рассмотреть вопросы оплаты труда как экономической категории и как объекта бухгалтерского учета, осуществить анализ оплаты труда на основе учетной информации.To study the theoretical aspects of accounting for the remuneration of employees of an educational institution, the legal regulation of the remuneration of public sector employees. Consider the practical aspects of accounting payroll in a budgetary institution. Consider issues of remuneration as an economic category and as an object of accounting, to carry out an analysis of remuneration based on accounting informatio

Enhancing Discovery of Genetic Variants for Posttraumatic Stress Disorder Through Integration of Quantitative Phenotypes and Trauma Exposure Information

Funding Information: This work was supported by the National Institute of Mental Health / U.S. Army Medical Research and Development Command (Grant No. R01MH106595 [to CMN, IL, MBS, KJRe, and KCK], National Institutes of Health (Grant No. 5U01MH109539 to the Psychiatric Genomics Consortium ), and Brain & Behavior Research Foundation (Young Investigator Grant [to KWC]). Genotyping of samples was provided in part through the Stanley Center for Psychiatric Genetics at the Broad Institute supported by Cohen Veterans Bioscience . Statistical analyses were carried out on the LISA/Genetic Cluster Computer ( https://userinfo.surfsara.nl/systems/lisa ) hosted by SURFsara. This research has been conducted using the UK Biobank resource (Application No. 41209). This work would have not been possible without the financial support provided by Cohen Veterans Bioscience, the Stanley Center for Psychiatric Genetics at the Broad Institute, and One Mind. Funding Information: MBS has in the past 3 years received consulting income from Actelion, Acadia Pharmaceuticals, Aptinyx, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, and Roche/Genentech and has stock options in Oxeia Biopharmaceuticals and Epivario. In the past 3 years, NPD has held a part-time paid position at Cohen Veterans Bioscience, has been a consultant for Sunovion Pharmaceuticals, and is on the scientific advisory board for Sentio Solutions for unrelated work. In the past 3 years, KJRe has been a consultant for Datastat, Inc., RallyPoint Networks, Inc., Sage Pharmaceuticals, and Takeda. JLM-K has received funding and a speaking fee from COMPASS Pathways. MU has been a consultant for System Analytic. HRK is a member of the Dicerna scientific advisory board and a member of the American Society of Clinical Psychopharmacology Alcohol Clinical Trials Initiative, which during the past 3 years was supported by Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Dicerna, Ethypharm, Indivior, Lundbeck, Mitsubishi, and Otsuka. HRK and JG are named as inventors on Patent Cooperative Treaty patent application number 15/878,640, entitled “Genotype-guided dosing of opioid agonists,” filed January 24, 2018. RP and JG are paid for their editorial work on the journal Complex Psychiatry. OAA is a consultant to HealthLytix. All other authors report no biomedical financial interests or potential conflicts of interest. Funding Information: This work was supported by the National Institute of Mental Health/ U.S. Army Medical Research and Development Command (Grant No. R01MH106595 [to CMN, IL, MBS, KJRe, and KCK], National Institutes of Health (Grant No. 5U01MH109539 to the Psychiatric Genomics Consortium), and Brain & Behavior Research Foundation (Young Investigator Grant [to KWC]). Genotyping of samples was provided in part through the Stanley Center for Psychiatric Genetics at the Broad Institute supported by Cohen Veterans Bioscience. Statistical analyses were carried out on the LISA/Genetic Cluster Computer (https://userinfo.surfsara.nl/systems/lisa) hosted by SURFsara. This research has been conducted using the UK Biobank resource (Application No. 41209). This work would have not been possible without the financial support provided by Cohen Veterans Bioscience, the Stanley Center for Psychiatric Genetics at the Broad Institute, and One Mind. This material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting true views of the U.S. Department of the Army or the Department of Defense. We thank the investigators who comprise the PGC-PTSD working group and especially the more than 206,000 research participants worldwide who shared their life experiences and biological samples with PGC-PTSD investigators. We thank Mark Zervas for his critical input. Full acknowledgments are in Supplement 1. MBS has in the past 3 years received consulting income from Actelion, Acadia Pharmaceuticals, Aptinyx, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, and Roche/Genentech and has stock options in Oxeia Biopharmaceuticals and Epivario. In the past 3 years, NPD has held a part-time paid position at Cohen Veterans Bioscience, has been a consultant for Sunovion Pharmaceuticals, and is on the scientific advisory board for Sentio Solutions for unrelated work. In the past 3 years, KJRe has been a consultant for Datastat, Inc. RallyPoint Networks, Inc. Sage Pharmaceuticals, and Takeda. JLM-K has received funding and a speaking fee from COMPASS Pathways. MU has been a consultant for System Analytic. HRK is a member of the Dicerna scientific advisory board and a member of the American Society of Clinical Psychopharmacology Alcohol Clinical Trials Initiative, which during the past 3 years was supported by Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Dicerna, Ethypharm, Indivior, Lundbeck, Mitsubishi, and Otsuka. HRK and JG are named as inventors on Patent Cooperative Treaty patent application number 15/878,640, entitled ?Genotype-guided dosing of opioid agonists,? filed January 24, 2018. RP and JG are paid for their editorial work on the journal Complex Psychiatry. OAA is a consultant to HealthLytix. All other authors report no biomedical financial interests or potential conflicts of interest. Publisher Copyright: © 2021 Society of Biological PsychiatryBackground: Posttraumatic stress disorder (PTSD) is heritable and a potential consequence of exposure to traumatic stress. Evidence suggests that a quantitative approach to PTSD phenotype measurement and incorporation of lifetime trauma exposure (LTE) information could enhance the discovery power of PTSD genome-wide association studies (GWASs). Methods: A GWAS on PTSD symptoms was performed in 51 cohorts followed by a fixed-effects meta-analysis (N = 182,199 European ancestry participants). A GWAS of LTE burden was performed in the UK Biobank cohort (N = 132,988). Genetic correlations were evaluated with linkage disequilibrium score regression. Multivariate analysis was performed using Multi-Trait Analysis of GWAS. Functional mapping and annotation of leading loci was performed with FUMA. Replication was evaluated using the Million Veteran Program GWAS of PTSD total symptoms. Results: GWASs of PTSD symptoms and LTE burden identified 5 and 6 independent genome-wide significant loci, respectively. There was a 72% genetic correlation between PTSD and LTE. PTSD and LTE showed largely similar patterns of genetic correlation with other traits, albeit with some distinctions. Adjusting PTSD for LTE reduced PTSD heritability by 31%. Multivariate analysis of PTSD and LTE increased the effective sample size of the PTSD GWAS by 20% and identified 4 additional loci. Four of these 9 PTSD loci were independently replicated in the Million Veteran Program. Conclusions: Through using a quantitative trait measure of PTSD, we identified novel risk loci not previously identified using prior case-control analyses. PTSD and LTE have a high genetic overlap that can be leveraged to increase discovery power through multivariate methods.publishersversionpublishe

Phase relationships in the neodymium-magnesium alloy system

The Nd-Mg system was studied using differential thermal analysis (DTA), X-ray examination, metallography, and microprobe analysis. The following intermetallic compounds were found to exist and their crystal structures confirmed or determined: NdMg (cubic, cP2 CsCl type, melting point 800 \ub0C), NdMg2 (cubic, cF24 MgCu2 type, peritectic formation 3c755 \ub0C), NdMg3 (cubic, cF16 BiF3 type, melting point 780 \ub0C), and Nd5Mg41 (tetragonal, tI92 Ce5Mg41 type, decomposes peritectically at 560 \ub0C). The NdMg2 phase undergoes a eutectoidal decomposition at 660 \ub0C. Three eutectic equilibria were observed to occur at 42.5 at. pct Mg and 775 \ub0C, 64.5 at. pct Mg and 750 \ub0C, and 92.5 at. pct Mg and 545 \ub0C, respectively. In the Nd-rich alloys, previously determined data[15] concerning the Mg solubility in \u3b1-Nd (8.2 at. pct Mg, 48550 \ub0C) were accepted. The Mg solubility in \u3b2-Nd was evaluated as 34 at. pct Mg at 775 \ub0C. The \u3b2-Nd phase was observed to decompose eutectoidally at 17 at. pct Mg and 545 \ub0C. Moreover, in the Mgrich alloys, a metastable NdMg12 phase (tetragonal, tI26 ThMn12 type) was observed in samples quenched from the liquid. The general properties of the Nd-Mg phases are compared with those of the R-Mg compounds and briefly discussed. \ua9 1990 The Metallurgical of Society of AIME